Comparison of antithrombin III assays using biological and chromogenic substrates

Summary. Antithrombin III (At III) levels in plasma samples were determined by incubation of diluted plasma with thrombin, either with or without heparin, followed by measurement of residual thrombin using clotting and amidolytic methods. All assays were of multidose bioassay design suitable for parallel line analysis. Assays without heparin showed only a small difference between amidolytic and clotting methods, which was not significant at the 95% level. Assays with heparin showed a much larger difference between clotting and amidolytic methods which is shown to be attributable to the heat defibrination step used in the clotting assay. Heat defibrination and ancrod defibrination methods are compared using the amidolytic heparin cofactor assay and it is shown that heat defibrination can cause the loss of nearly 50% of the functional At III in a reconstituted freeze‐dried plasma which was used as a standard. No loss occurs when ancrod is used for defibrination. It is an advantage of the amidolytic heparin cofactor assay that defibrination is not required.

[1]  U. Christensen,et al.  Requirements for Valid Assays of Clotting Enzymes Using Chromogenic Substrates , 1980, Thrombosis and Haemostasis.

[2]  T. Kirkwood,et al.  An International Collaborative Study Establishing a Reference Preparation for Antithrombin III , 1980, Thrombosis and Haemostasis.

[3]  T. Barrowcliffe.  Studies of Heparin Binding to Antithrombin III by Crossed Immunoelectrophoresis , 1979, Thrombosis and Haemostasis.

[4]  R. Bick.  Biological antithrombin III levels. , 1978, JAMA.

[5]  R. Landolfi,et al.  Amidolytic assay of thrombin bound to alpha2-macroglobulin in plasma. , 1977, Haemostasis.

[6]  I. Kovács,et al.  A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation. , 1976, Thrombosis research.

[7]  M. Donati,et al.  Defibrinogenation Procedures for Antithrombin III (AT-III) Biological Assay , 1975, Thrombosis and Haemostasis.

[8]  S. Wessler,et al.  Plasma antithrombin III: a quantitative assay of biological activity. , 1975, Thrombosis research.

[9]  D. Pepper,et al.  Investigations on Antithrombin III in Normal Plasma and Serum , 1975, British journal of haematology.

[10]  C. Rizza,et al.  A New Assay for the Measurement of Total Progressive Antithrombin , 1975, British journal of haematology.

[11]  M. Blombäck,et al.  The assay of antithrombin using a synthetic chromogenic substrate for thrombin. , 1974, Thrombosis Research.

[12]  P. Howie,et al.  A Method of Antithrombin Estimation using Plasma Defibrinated with Ancrod , 1973, British journal of haematology.

[13]  C. Horne,et al.  Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. , 1970, Lancet.

[14]  U. Abildgaard,et al.  Assay of Progressive Antithrombin in Plasma , 1970, Thrombosis and Haemostasis.

[15]  R. Biggs,et al.  Antithrombin III, Antifactor Xa and Heparin , 1970 .

[16]  M. Steinbuch,et al.  α2-Macroglobulin as Progressive Antithrombin , 1967, Nature.

[17]  O. Egeberg.  Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[18]  J. F. Johnson,et al.  An Antithrombin Reaction Related to Prothrombin Activation , 1953 .